The role of microRNA profiling in prognosticating progression in Ta and T1 urinary bladder cancer

Urologic Oncology: Seminars and Original Investigations

Volumn 32, Issue 5, 2014, Pages 613-618

  Segersten, Ulrika ^a   Spector, Yael ^b   Goren, Yaron ^b   Tabak, Sarit ^b   Malmström, Per Uno ^a  

^a UPPSALA UNIVERSITY   (Sweden)

^b ROSETTA GENOMICS LTD   (Israel)

Author keywords

Bladder neoplasms; Case control study; MicroRNA; Prognosis

Indexed keywords

FORMALDEHYDE; MICRORNA; MIR 10A 5P; MIR 130A 3P; MIR 31 5P; PARAFFIN; TUMOR MARKER; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BLADDER CANCER; CANCER GROWTH; CANCER RISK; CANCER STAGING; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MICROARRAY ANALYSIS; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RISK ASSESSMENT; RNA EXTRACTION; T1 URINARY BLADDER CANCER; TA URINARY BLADDER CANCER; BLADDER TUMOR; DISEASE COURSE; DNA MICROARRAY; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; KAPLAN MEIER METHOD; METABOLISM; MIDDLE AGED; PATHOLOGY; PROGNOSIS; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MICRORNAS; MIDDLE AGED; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROGNOSIS; PROSPECTIVE STUDIES; URINARY BLADDER NEOPLASMS;

EID: 84902537085     PISSN: 10781439     EISSN: 18732496     Source Type: Journal    
DOI: 10.1016/j.urolonc.2013.11.001     Document Type: Article

References (30)

1. Malmström P.U. Bladder tumours: time for a paradigm shift?. BJU Int 2011, 107:1543-1545.
2. Fernandez-Gomez J., Madero R., Solsona E., et al. The EORTC tables overestimate the risk of recurrence and progression in patients with non-muscle-invasive bladder cancer treated with bacillus Calmette-Guerin: external validation of the EORTC risk tables. Eur Urol 2011, 60:423-430.
3. Esquela-Kerscher A., Slack F.J. Oncomirs-microRNAs with a role in cancer. Nat Rev Cancer 2006, 6:259-269.
4. Garzon R., Marcucci G., Croce C.M. Targeting microRNAs in cancer: rationale, strategies and challenges. Nat Rev Drug Discov 2010, 9:775-789.
5. Friedman R.C., Farh K.K., Burge C.B., Bartel D.P. Most mammalian mRNAs are conserved targets of microRNAs. Genome Res 2009, 19:92-105.
6. Iorio M.V., Casalini P., Piovan C., Braccioli L., Tagliabue E. Breast cancer and microRNAs: therapeutic impact. Breast 2011, 20(Suppl. 3):S63-S70.
7. Markou A., Liang Y., Lianidou E. Prognostic, therapeutic and diagnostic potential of microRNAs in non-small cell lung cancer. Clin Chem Lab Med 2011, 49:1591-1603.
8. Benjamin H., Lebanony D., Rosenwald S., et al. A diagnostic assay based on microRNA expression accurately identifies malignant pleural mesothelioma. J Mol Diagn 2010, 12:771-779.
9. Fridman E., Dotan Z., Barshack I., et al. Accurate molecular classification of renal tumors using microRNA expression. J Mol Diagn 2010, 12:687-696.
10. Gilad S., Lithwick-Yanai G., Barshack I., et al. Classification of the four main types of lung cancer using a microRNA-based diagnostic assay. J Mol Diagn 2012, 14:510-517.
11. Meiri E., Mueller W.C., Rosenwald S., et al. A second-generation microRNA-based assay for diagnosing tumor tissue origin. Oncologist 2012, 17:801-812.
12. Rosenfeld N., Aharonov R., Meiri E., et al. MicroRNAs accurately identify cancer tissue origin. Nat Biotechnol 2008, 26:462-469.
13. Varadhachary G.R., Spector Y., Abbruzzese J.L., et al. Prospective gene signature study using microRNA to identify the tissue of origin in patients with carcinoma of unknown primary. Clin Cancer Res 2011, 17:4063-4070.
14. Catto J.W., Alcaraz A., Bjartell A.S., et al. MicroRNA in prostate, bladder, and kidney cancer: a systematic review. Eur Urol 2011, 59:671-681.
15. Zhai H., Ju J. Implications of microRNAs in colorectal cancer development, diagnosis, prognosis, and therapeutics. Front Genet 2011, 2. [Epub ahead of print].
16. Fendler A., Stephan C., Yousef G.M., Jung K. MicroRNAs as regulators of signal transduction in urological tumors. Clin Chem 2011, 57:954-968.
17. Guancial E.A., Bellmunt J., Yeh S., Rosenberg J.E., Berman D.M. The evolving understanding of microRNA in bladder cancer. Urol Oncol 2013, [Epub ahead of print].
18. Catto J.W., Miah S., Owen H.C., et al. Distinct microRNA alterations characterize high- and low-grade bladder cancer. Cancer Res 2009, 69:8472-8481.
19. Dyrskjot L., Ostenfeld M.S., Bramsen J.B., et al. Genomic profiling of microRNAs in bladder cancer: miR-129 is associated with poor outcome and promotes cell death in vitro. Cancer Res 2009, 69:4851-4860.
20. Friedman J.M., Liang G., Liu C.C., et al. The putative tumor suppressor microRNA-101 modulates the cancer epigenome by repressing the polycomb group protein EZH2. Cancer Res 2009, 69:2623-2629.
21. Han Y., Chen J., Zhao X., et al. MicroRNA expression signatures of bladder cancer revealed by deep sequencing. PLoS One 2011, 6:e18286.
22. Lin T., Dong W., Huang J., et al. MicroRNA-143 as a tumor suppressor for bladder cancer. J Urol 2009, 181:1372-1380.
23. Neely L.A., Rieger-Christ K.M., Neto B.S., et al. A microRNA expression ratio defining the invasive phenotype in bladder tumors. Urol Oncol 2010, 28:39-48.
24. Veerla S., Lindgren D., Kvist A., et al. MiRNA expression in urothelial carcinomas: important roles of miR-10a, miR-222, miR-125b, miR-7 and miR-452 for tumor stage and metastasis, and frequent homozygous losses of miR-31. Int J Cancer 2009, 124:2236-2242.
25. Rosenberg E., Baniel J., Spector Y., et al. Predicting progression of bladder urothelial carcinoma using microRNA expression. BJU Int 2013, 112:1027-1034.
26. Gilad S., Meiri E., Yogev Y., et al. Serum microRNAs are promising novel biomarkers. PLoS One 2008, 3:e3148.
27. Benjamini Y., Drai D., Elmer G., Kafkafi N., Golani I. Controlling the false discovery rate in behavior genetics research. Behav Brain Res 2001, 125:279-284.
28. Garzon R., Pichiorri F., Palumbo T., et al. MicroRNA fingerprints during human megakaryocytopoiesis. Proc Natl Acad Sci U S A 2006, 103:5078-5083.
29. Ohuchida K., Mizumoto K., Lin C., et al. MicroRNA-10a is overexpressed in human pancreatic cancer and involved in its invasiveness partially via suppression of the HOXA1 gene. Ann Surg Oncol 2012, 19:2394-2402.
30. Gaur A., Jewell D.A., Liang Y., et al. Characterization of microRNA expression levels and their biological correlates in human cancer cell lines. Cancer Res 2007, 67:2456-2468.